FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2052596 · Received April 13, 2011

Report

Report Number
2124215-2011-04266
Event Type
Malfunction
Date Received
April 13, 2011
Date of Event
February 28, 2011
Report Date
February 28, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE REMAINS IN SERVICE. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED AT THIS TIME, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT IMPLANTED WITH THIS DEFIBRILLATOR EXPERIENCED AN ATRIAL ARRHYTHMIA THAT CONDUCTED INTO THE VENTRICLE AND RAISED THE VENTRICULAR RATE TO 150 BPM. AS A RESULT, THE DEVICE DELIVERED SHOCKS UNTIL THERAPY WAS EXHAUSTED. TECHNICAL SERVICES WAS CONTACTED AND DISCUSSED PROGRAMMING OPTIONS. THERE WERE NO REPORTED ADVERSE PATIENT EFFECTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E102

Patients

Seq Age Sex Outcome Treatment
1 58 YR 0184| E102